Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR -mutant and EGFR -wild type nonsquamous non-small cell lung cancer-Reference-Cited by-同舟云学术

Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR -mutant and EGFR -wild type nonsquamous non-small cell lung cancer

Published:2018-09-27 Issue:12 Volume:9 Page:1648-1655
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Huang Yu-Chen¹,Shen Shih-Min¹,Liu Chien-Ying¹,Pavlidis Stelios²,Wang Chih-Liang¹,Ko How-Wen¹,Chung Fu-Tsai¹,Lin Tin-Yu¹,Feng Po-Hao³,Lee Kang-Yun³,Guo Yi-Ke²,Yang Cheng-Ta¹,Kuo Chih-Hsi Scott¹²^ORCID

Affiliation:

1. Division of Lung Cancer and Interventional Bronchoscopy, Department of Thoracic Medicine; Chang Gung Memorial Hospital; Taipei Taiwan

2. Department of Computing; Data Science Institute, Imperial College London; London UK

3. Department of Thoracic Medicine; Taipei Medical University Shuang Ho Hospital; New Taipei City Taiwan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12875/fullpdf

Reference31 articles.

1. Targeting the tumour stroma to improve cancer therapy;Valkenburg;Nat Rev Clin Oncol,2018

2. Cell adhesion and matrix stiffness: Coordinating cancer cell invasion and metastasis;Gkretsi;Front Oncol,2018

3. Accessories to the crime: Functions of cells recruited to the tumor microenvironment;Hanahan;Cancer Cell,2012

4. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium;Karnezis;Cancer Cell,2012

5. VEGF and angiopoietin signaling in tumor angiogenesis and metastasis;Saharinen;Trends Mol Med,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis;Scientific Reports;2022-03-15

2. The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study;Pharmaceuticals;2020-10-23

3. The optimal timing and courses of bevacizumab added to chemotherapy for non-squamous non-small cell lung cancer: revelations from the real-world experience in a single Chinese cancer center;Annals of Translational Medicine;2020-10